ArticleBritish journal of cancer2008

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

J F Knight et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.